Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02565823 · ClinicalTrials.gov registry record · NA

The Effects of Exercise of Secreted Factors From Muscle and Adipose Tissue

A NA study, sponsored by Joslin Diabetes Center.

Completed
Registry status
NA
Development phase
12
Enrollment target

NCT02565823 is a NA study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02565823, a NA study, has completed, sponsored by Joslin Diabetes Center.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

The purpose of this study is to find out whether exercise leads to changes in the blood that are produced by exercised muscles and if these changes produce new hormones that affect the body's regulation of sugar and body weight.

Interventions

  • OTHER Exercise bout

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2015-10
Est. Completion 2016-03
Phase NA

Sponsor

Joslin Diabetes Center

73 total trials

What the Registry Record Tells You About NCT02565823

The ClinicalTrials.gov registry entry for NCT02565823 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Exercise bout is the first listed.

NCT02565823 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02565823 about?

NCT02565823 is a clinical study titled "The Effects of Exercise of Secreted Factors From Muscle and Adipose Tissue". The purpose of this study is to find out whether exercise leads to changes in the blood that are produced by exercised muscles and if these changes produce new hormones that affect the body's regulation of sugar and body weight.

What is the current status of trial NCT02565823?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2015-10. Estimated completion is 2016-03.

What interventions are being tested in trial NCT02565823?

The interventions under investigation include: Exercise bout (OTHER).

Who is sponsoring clinical trial NCT02565823?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.